Clinical Trial Update: Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (NICOFIB) is evaluating the efficacy and safety of nicotinamide in patients with liver fibrosis, with recruitment ongoing in the contex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Non-alcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Fatty Liver, Obesity | Phase 2 | Status: RECRUITING